BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 25075823)

  • 1. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012).
    Boston SE; Lu X; Culp WT; Montinaro V; Romanelli G; Dudley RM; Liptak JM; Mestrinho LA; Buracco P
    J Am Vet Med Assoc; 2014 Aug; 245(4):401-7. PubMed ID: 25075823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
    Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
    Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998-2011).
    Tuohy JL; Selmic LE; Worley DR; Ehrhart NP; Withrow SJ
    J Am Vet Med Assoc; 2014 Dec; 245(11):1266-73. PubMed ID: 25406707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.
    Giacobino D; Camerino M; Riccardo F; Cavallo F; Tarone L; Martano M; Dentini A; Iussich S; Lardone E; Franci P; Valazza A; Manassero L; Del Magno S; De Maria R; Morello E; Buracco P
    Vet Comp Oncol; 2021 Dec; 19(4):651-660. PubMed ID: 33751759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma.
    Ottnod JM; Smedley RC; Walshaw R; Hauptman JG; Kiupel M; Obradovich JE
    Vet Comp Oncol; 2013 Sep; 11(3):219-29. PubMed ID: 23909996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006-2012).
    Kawabe M; Mori T; Ito Y; Murakami M; Sakai H; Yanai T; Maruo K
    J Am Vet Med Assoc; 2015 Nov; 247(10):1146-53. PubMed ID: 26517618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of surgical excision and evaluation of factors associated with survival time in dogs with lingual neoplasia: 97 cases (1995-2008).
    Culp WT; Ehrhart N; Withrow SJ; Rebhun RB; Boston S; Buracco P; Reiter AM; Schallberger SP; Aldridge CF; Kent MS; Mayhew PD; Brown DC
    J Am Vet Med Assoc; 2013 May; 242(10):1392-7. PubMed ID: 23634684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
    Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
    J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
    MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
    Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma.
    Treggiari E; Grant JP; North SM
    J Vet Med Sci; 2016 Jun; 78(5):845-50. PubMed ID: 26781703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
    Grosenbaugh DA; Leard AT; Bergman PJ; Klein MK; Meleo K; Susaneck S; Hess PR; Jankowski MK; Jones PD; Leibman NF; Johnson MH; Kurzman ID; Wolchok JD
    Am J Vet Res; 2011 Dec; 72(12):1631-8. PubMed ID: 22126691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical excision of anal sac apocrine gland adenocarcinomas with and without adjunctive chemotherapy in dogs: 42 cases (2005-2011).
    Potanas CP; Padgett S; Gamblin RM
    J Am Vet Med Assoc; 2015 Apr; 246(8):877-84. PubMed ID: 25835172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK.
    Verganti S; Berlato D; Blackwood L; Amores-Fuster I; Polton GA; Elders R; Doyle R; Taylor A; Murphy S
    J Small Anim Pract; 2017 Jan; 58(1):10-16. PubMed ID: 28094857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of survival time and prognostic factors for dogs with small intestinal adenocarcinoma treated by tumor excision with or without adjuvant chemotherapy.
    Smith AA; Frimberger AE; Moore AS
    J Am Vet Med Assoc; 2019 Jan; 254(2):243-250. PubMed ID: 30605388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of 42 dogs with scapular tumors treated by scapulectomy: a Veterinary Society of Surgical Oncology (VSSO) retrospective study (1995-2010).
    Montinaro V; Boston SE; Buracco P; Culp WT; Romanelli G; Straw R; Ryan S
    Vet Surg; 2013 Nov; 42(8):943-50. PubMed ID: 24433298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and prognostic factors following curative-intent surgery for oral tumours in dogs: 234 cases (2004 to 2014).
    Sarowitz BN; Davis GJ; Kim S
    J Small Anim Pract; 2017 Mar; 58(3):146-153. PubMed ID: 28224623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
    Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
    J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the melanoma vaccine in 38 dogs: The South African experience.
    McLean JL; Lobetti RG
    J S Afr Vet Assoc; 2015 Apr; 86(1):1246. PubMed ID: 26016668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.